文献速递呼吸衰竭与机械通气心脑血管急症重症综合管理与镇静镇痛

肾功能不全改善风险分层并可能要求改变中高危急性肺栓塞的管理:多中心队列研究及外部验证结果

Renal dysfunction improves risk stratification and may call for a change in the management of intermediate- and high-risk acute pulmonary embolism: results from a multicenter cohort study with external validation.
PubMed 文献 · Crit Care · 2021-02-09
一句话结论在ESC预后模型基础上加入eGFRMDRD4定义的肾功能不全可改善急性肺栓塞30天死亡预测并导致中高危类别内风险再分类。

该多中心、非干预性回顾性事后分析基于前瞻性收集的连续确诊急性肺栓塞队列,按ESC指南分层,纳入1943例患者(平均年龄67.3岁(17.1),50.4%女性),107例(5.5%)30天死亡。四种变量的肾脏病饮食改良(MDRD)公式(eGFRMDRD4)预测死亡最准确,477例(24.5%)eGFRMDRD4<60 ml/min。在ESC模型上加入eGFRMDRD4信息改善了模型拟合、区分能力和校准,再分类参数显著提高,产生18%的预测死亡率再分类(p<0.001)。在RIETE注册队列14234例合格患者中的外部验证证实了上述发现,Harrell C指数和再分类参数显著改善。

要点

  • 在1943例急性肺栓塞患者中,107例(5.5%)30天死亡,477例(24.5%)eGFRMDRD4<60 ml/min。
  • eGFRMDRD4公式在三种eGFR公式中预测死亡最准确。
  • 加入eGFRMDRD4信息后ESC模型拟合、区分能力和校准均改善,再分类参数显著提高(18%再分类,p<0.001)。
  • 风险类别再分类:63.1%从中低危再分类至eGFR定义的中高危,15.8%从中高危再分类至eGFR定义的中低危,21.0%从中高危再分类至eGFR定义的高危。
  • RIETE注册队列14234例合格患者外部验证证实Harrell C指数和再分类参数显著改善。

适用人群与场景

  • 连续确诊的急性肺栓塞患者,按ESC指南进行风险分层。

诊断标准与关键阈值

  • 肾功能不全定义为eGFRMDRD4<60 ml/min。

研究设计与关键结果

  • 研究类型:多中心、非干预性回顾性事后分析,基于前瞻性收集的队列。
  • 样本量:1943例患者(平均年龄67.3岁(17.1),50.4%女性)。
  • 主要终点:30天死亡率,107例(5.5%)死亡。
  • eGFRMDRD4公式预测死亡最准确;477例(24.5%)eGFRMDRD4<60 ml/min。
  • 有肾功能不全的患者中,中低危和高危肺栓塞的观察死亡率高于无肾功能不全者。
  • 加入eGFRMDRD4信息改善ESC模型拟合、区分能力和校准。
  • 再分类参数显著提高,产生18%的预测死亡率再分类(p<0.001)。
  • 风险类别再分类:63.1%从中低危至eGFR定义的中高危,15.8%从中高危至eGFR定义的中低危,21.0%从中高危至eGFR定义的高危。

证据类型、等级与局限

  • 证据类型:多中心回顾性事后分析,基于前瞻性队列,并包含外部验证。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在ESC预后模型基础上加入eGFRMDRD4定义的肾功能不全,可对中危和高危肺栓塞类别进行风险再分类。
  • 作者认为,整合肾功能不全的风险分层对急性肺栓塞治疗管理的影响需要进一步研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Renal dysfunction influences outcomes after pulmonary embolism (PE). We aimed to determine the incremental value of adding renal dysfunction, defined by estimated glomerular filtration rate (eGFR), on top of the European Society of Cardiology (ESC) prognostic model, for the prediction of 30-day mortality in acute PE patients, which in turn could lead to the optimization of acute PE management.

METHODS: We performed a multicenter, non-interventional retrospective post hoc analysis based on a prospectively collected cohort including consecutive confirmed acute PE stratified per ESC guidelines. We first identified which of three eGFR formulae most accurately predicted death. Changes in global model fit, discrimination, calibration and reclassification parameters were evaluated with the addition of eGFR to the prognostic model.

RESULTS: Among 1943 patients (mean age 67.3 (17.1), 50.4% women), 107 (5.5%) had died at 30 days. The 4-variable Modification of Diet in Renal Disease (eGFRMDRD4) formula predicted death most accurately. In total, 477 patients (24.5%) had eGFRMDRD4 < 60 ml/min. Observed mortality was higher for intermediate-low-risk and high-risk PE in patients with versus without renal dysfunction. The addition of eGFRMDRD4 information improved model fit, discriminatory capacity, and calibration of the ESC model. Reclassification parameters were significantly increased, yielding 18% reclassification of predicted mortality (p < 0.001). Predicted mortality reclassifications across risk categories were as follows: 63.1% from intermediate-low risk to eGFR-defined intermediate-high risk, 15.8% from intermediate-high risk to eGFR-defined intermediate-low risk, and 21.0% from intermediate-high risk to eGFR-defined high risk. External validation in a cohort of 14,234 eligible patients from the RIETE registry confirmed our findings with a significant improvement of Harrell's C index and reclassification parameters.

CONCLUSION: The addition of eGFRMDRD4-derived renal dysfunction on top of the prognostic algorithm led to risk reclassification within the intermediate- and high-risk PE categories. The impact of risk stratification integrating renal dysfunction on therapeutic management for acute PE requires further studies.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Chopard R, Jimenez D, Serzian G, et al. Renal dysfunction improves risk stratification and may call for a change in the management of intermediate- and high-risk acute pulmonary embolism: results from a multicenter cohort study with external validation. Crit Care. 2021. PMID: 33563311. doi:10.1186/s13054-021-03458-z

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。